# Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

> **NCT06125756** · EARLY_PHASE1 · UNKNOWN · sponsor: **Affiliated Hospital of Guangdong Medical University** · enrollment: 9 (estimated)

## Conditions studied

- Hemophilia B Without Inhibitor

## Interventions

- **DRUG:** Low dose KL001
- **DRUG:** Middle dose KL001
- **DRUG:** High dose KL001

## Key facts

- **NCT ID:** NCT06125756
- **Lead sponsor:** Affiliated Hospital of Guangdong Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-20
- **Primary completion:** 2024-09-20
- **Final completion:** 2025-10-30
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2023-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06125756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06125756, "Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06125756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*